Merlini, Giampaolo
Dispenzieri, Angela
Sanchorawala, Vaishali
Schönland, Stefan O.
Palladini, Giovanni
Hawkins, Philip N.
Gertz, Morie A.
Article History
First Online: 25 October 2018
Competing interests
: G.M. is on the advisory board for Caelum, Janssen and Pfizer and has received travel support from Janssen and Prothena. A.D. receives research support from Alnylam, Celgene, GlaxoSmithKline, Pfizer and Takeda and has received research support from Prothena. V.S. sits on the advisory boards of Caelum, Janssen, receives research support from Celgene, Janssen and Takeda and has received research support from Prothena. S.O.S. has received honoraria and research support from Prothena and receives honoraria from Janssen, travel support from Jazz and Takeda and research support from Janssen and Sanofi. G.P. sits on the advisory board of Janssen, has received honoraria from Prothena and receives honoraria from Sebia and travel support from Celgene. P.N.H. receives honoraria from Alnylam and GlaxoSmithKline and is a director and stockholder of Pentraxin Therapeutics. M.A.G. receives honoraria from Abbvie, Alnylam, Amgen, Annexon, Appellis, Celgene, Ionis, Janssen, Johnson and Johnson, Medscape, Physicians Education Resource, Prothena, Research to Practice, Spectrum and Teva and receives research support from Spectrum.